EXPERT OPIN INV DRUG 润色咨询

EXPERT OPINION ON INVESTIGATIONAL DRUGS

出版年份:1994 年文章数:1043 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=bd026984, cover=https://img.medsci.cn/images/journal/cover/2021/nIf_202109271315017420.jpg, fullname=EXPERT OPINION ON INVESTIGATIONAL DRUGS, abbr=EXPERT OPIN INV DRUG, pyear=1994, frequence=Monthly, articleNumbers=1043, citedSelf2015=2.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1354-3784, greenSci=https://www.greensci.net/search?kw=1354-3784, scijournal=https://www.scijournal.org/impact-factor-of-EXPERT-OPIN-INV-DRUG.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.803, medsciHotlight=1.969, medsciHotlight5year=3.05866, citescore=7.9, hIndex=104, impactFactor=6.1, orgnization=Taylor and Francis Ltd., orgnizationUrl=http://www.informapharmascienc, country=United Kingdom, countryCn=英国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.tandfonline.com/toc/ieid20/current, websiteHits=7384, guideForAuthor=null, guideForAuthorHits=3, submitWebsite=https://mc.manuscriptcentral.com/eoid, submitWebsiteHits=1737, content=Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3784.<br /><br />Expert Opinion on Investigational Drugs (EOID) is a monthly peer-reviewed journal, evaluating developments in pharmaceutical research, from animal studies through to the launch of a new medicine. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than simply reviewing the available data. Each issue of the journal also contains Editorials, Drug Evaluations, Clinical Trial Reports, Meeting Highlights and Paper Evaluations. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Investigational Drugs adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas., totalCites=6364, brief=EXPERT OPIN INV DRUG杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=EXPERT OPIN INV DRUG在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=bd026984'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=598, tagName=新药, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.39), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.21), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.14), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=7.9)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.938), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.168), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.365), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.33), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.803)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology (medical) , rank=24/237), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology , rank=47/301)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY - SCIE , rank=25/270)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3784[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Expert Opinion on Investigational Drugs[ta], article_number=102, article_number_cn=10, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
EXPERT OPIN INV DRUG/EXPERT OPINION ON INVESTIGATIONAL DRUGS
ISSN
1354-3784
影响指数话题
预警等级
MedSci期刊指数
2.803 (MedSci实时期刊指数) | 3.05866 (5年期刊指数)
CiteScore值
7.9
h-index
104
h5-median
暂无数据
出版社/管理机构
杂志由 Taylor and Francis Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Monthly
出版年份
1994
是否OA
部分OA
被收录情况
Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
PHARMACOLOGY & PHARMACY - SCIE 25/270
中科院分区
大类:医学 2区
小类:医学 2 区